SOL-USD vs. NOVO-B.CO

Last updated Jun 14, 2026

SOL-USD (Solana) is a cryptocurrency, while NOVO-B.CO (Novo Nordisk A/S) is a stock. Over the past 5 years, SOL-USD returned 12.17%/yr vs 19.41%/yr for NOVO-B.CO. At a 0.09 correlation, their price movements are largely independent.

Performance

SOL-USD vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Solana (SOL-USD) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

SOL-USD is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, SOL-USD achieves a -44.76% return, which is significantly lower than NOVO-B.CO's -10.15% return.

SOL-USD

• 1D: 0.85%
• 1M: -25.39%
• YTD: -44.76%
• 6M: -48.38%
• 1Y: -53.76%
• 3Y*: 68.07%
• 5Y*: 12.17%
• 10Y*: —

NOVO-B.CO

• 1D: 1.53%
• 1M: -5.28%
• YTD: -10.15%
• 6M: -8.95%
• 1Y: -41.84%
• 3Y*: 6.83%
• 5Y*: 19.41%
• 10Y*: 17.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SOL-USD vs. NOVO-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SOL-USD Solana	-44.76%	-34.09%	85.68%	919.96%	-94.13%	11,143.63%	81.60%
NOVO-B.CO Novo Nordisk A/S	-10.15%	-39.54%	-15.04%	214.95%	23.90%	65.39%	20.87%

Correlation

The correlation between SOL-USD and NOVO-B.CO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (All Time) Calculated using the full available price history since Apr 10, 2020	0.09

Return for Risk

SOL-USD vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOL-USD

SOL-USD Risk / Return Rank: 51
SOL-USD Sharpe Ratio Rank: 44
SOL-USD Sortino Ratio Rank: 51
SOL-USD Omega Ratio Rank: 52
SOL-USD Calmar Ratio Rank: 60
SOL-USD Martin Ratio Rank: 51

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 13
NOVO-B.CO Sharpe Ratio Rank: 10
NOVO-B.CO Sortino Ratio Rank: 14
NOVO-B.CO Omega Ratio Rank: 12
NOVO-B.CO Calmar Ratio Rank: 13
NOVO-B.CO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOL-USD vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Solana (SOL-USD) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SOL-USD	NOVO-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	-0.74	-0.77	+0.03
Sortino ratio: Return per unit of downside risk	-0.98	-0.89	-0.09
Omega ratio: Gain probability vs. loss probability	0.91	0.88	+0.03
Calmar ratio: Return relative to maximum drawdown	-0.72	-0.79	+0.07
Martin ratio: Return relative to average drawdown	-1.16	-1.17	+0.02

SOL-USD vs. NOVO-B.CO - Sharpe Ratio Comparison

The current SOL-USD Sharpe Ratio is -0.74, which is comparable to the NOVO-B.CO Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of SOL-USD and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SOL-USD vs. NOVO-B.CO - Drawdown Comparison

The maximum SOL-USD drawdown since its inception was -96.27%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for SOL-USD and NOVO-B.CO.

Drawdown Indicators

	SOL-USD	NOVO-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-96.27%	-74.86%	-21.41%
Max Drawdown (1Y) Largest decline over 1 year	-74.89%	-54.48%	-20.41%
Max Drawdown (3Y) Largest decline over 3 years	-76.28%	-74.86%	-1.42%
Max Drawdown (5Y) Largest decline over 5 years	-96.27%	-74.86%	-21.41%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.86%	—
Current Drawdown Current decline from peak	-73.76%	-67.88%	-5.88%
Average Drawdown Average peak-to-trough decline	-51.42%	-12.38%	-39.04%
Ulcer Index Depth and duration of drawdowns from previous peaks	53.06%	36.72%	+16.34%

Volatility

SOL-USD vs. NOVO-B.CO - Volatility Comparison

Solana (SOL-USD) has a higher volatility of 17.62% compared to Novo Nordisk A/S (NOVO-B.CO) at 12.08%. This indicates that SOL-USD's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SOL-USD	NOVO-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.62%	12.08%	+5.54%
Volatility (6M) Calculated over the trailing 6-month period	46.90%	40.71%	+6.19%
Volatility (1Y) Calculated over the trailing 1-year period	60.08%	55.70%	+4.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	82.35%	58.93%	+23.42%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	99.82%	45.48%	+54.34%

Frequently Asked Questions

Can I hold both SOL-USD and NOVO-B.CO in my portfolio?

SOL-USD and NOVO-B.CO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.